Follow Bio-in-tech for news in drug discovery
The global AI drug discovery market is valued at approximately $2.9-$25 billion in 2026 and is growing at a CAGR of 11-25%. Explore market size by segment, region, and analyst forecast, plus hype vs. reality, regulatory updates, and 2026 milestones to watch.
Introduction Bringing a new drug to market costs an average of $2.6 billion and takes over a decade — and despite enormous scientific investment, roughly 90% of drug candidates still fail in clinical trials. Machine learning is changing that math.…
Artificial intelligence is no longer a futuristic concept in pharmaceutical research – it is now a core driver of innovation across the drug discovery lifecycle. In 2026, AI-powered platforms are helping biotech startups identify novel drug targets, design optimized molecules,…
Introduction The cost of discovering and developing a new drug has reached unprecedented levels, often exceeding $2 billion and spanning 10–15 years from initial research to market approval. For pharmaceutical and biotech companies, this economic reality is no longer sustainable—especially…
Artificial intelligence (AI) is fundamentally reshaping how new drugs are discovered, designed, and brought to market. In 2026, AI in drug discovery is no longer an experimental add‑on used by a handful of biotech startups—it has become a core strategic…